Presentations

Want to find out about the latest developments from Celixir’s innovative research. Check out our calendar below which gives a list of upcoming and previous industry events where Celixir will be giving or has given presentations.

Presentations
Florence | 18 to 21 October 2016

Presentation by Celixir :

  • Fixing the So-called Unfixable: Regenerating Untreatable Fixed Myocardial Scar in Heart Failure Patients; A. Reginald, S. Sultan, L. Chapman, M. Evans, K, P. Antonitsis, S. Westaby and K. Anastasiadis

Celixir Posters :

  • Immunomodulatory Progenitor Cells: A Novel And Safe Allogeneic Therapy For Patients With Ischaemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting; S. Sultan, A. Reginald, L. Chapman, M. Evans, K, P. Antonitsis, S. Westaby and K. Anastasiadis
  • Tendoncel Phase II Placebo Controlled Randomized Clinical Trial Results For A Novel Allogeneic Regenerative Topical Medicine In Treatment Of Chronic Tendon Injury; A. Reginald, S. Sultan, A. Mousiadou, L. Chapman, M. Evans & G. Panagiotis
Helsinki, Finland | 17-20 September 2015

Celixir studies presented:

  • ESGCT 2015 Reginald et al. Tendonce Phase II Placebo controlled Randomized Clinical Trial results of a novel allogeneic regenerative topical medicine in treatment of Chronic Tendon injury
  • ESGCT 2015 Sultan et al. Isolation of immunomodulatory progenitor cells of mesodermal lineage
  • ESGCT 2015 Sultan et al. Immunomodulatory progenitor cells- a novel allogeneic therapy for patients with ischaemic cardiomyopathy undergoing coronary artery bypass grafting
London | August 10-12, 2015

Celixir studies presented:

  • CGT 2015 Reginald et al. A Double Blind Randomised Placebo Controlled Phase IIb Clinical Trial to Study the Efficacy and Safety of Tendonce in Lateral Epicondylitis
Stockholm, Sweden | 24th-27th June 2015

Celixir studies presented:

  • ISSCR 2015 Sultan et al. Immunomodulatory Progenitor Cells A Novel Allogeneic Therapy for Patients with Ischaemic Cardiomyopathy undergoing CABG
  • ISSCR 2015 Sultan et al. Isolation of Immunomodulatory Progenitor Cells A Novel and Distinct Mesodermal Progenitor Cell
  • ISSCR 2015 Sultan et al. Tendonce Phase II Placebo controlled Randomized Clinical Trial results of a novel allogeneic regenerative topical medicine in treatment of Chronic Tendon injury
Strathclyde, Glasgow | 9th-11th June 2015

Celixir studies presented:

  • BSGCT 2015 Sultan et al. Isolation of iMP Cells A Novel and Distinct Mesodermal Progenitor Cell
Cambridge | 22-24 April 2015

Celixir studies presented:

  • The Biology of Regenerative Medicines 2015 Sultan et al. Isolation of iMP Cells of Mesodermal Lineage From Healthy Peripheral Blood
Istanbul, Turkey | 26th-29th March 2015

Celixir studies presented:

  • ESCVS 2015 Roberts et al. Myocardial Regeneration with Cell Therapy – Heartcel
Twitter Feed